Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Michalakis Averkiou

Michalakis Averkiou, Lakatamia CY

Patent application numberDescriptionPublished
20100298706RESPIRATORY-GATED THERAPY ASSESSMENT WITH ULTRASONIC CONTRAST AGENTS - An ultrasonic imaging apparatus and method are described for monitoring the progress of therapy for pathology such as lesions, tumors, and metastases by means of contrast agent imaging. A sequence of images are acquired as a bolus of contrast agent infuses the tissue containing the pathology. A contrast wash-in time parameter is calculated for both the tumor and normal tissue, and a ratio is calculated of the two wash-in time parameters (called WITR) which removes the effects of variations in the procedure from one therapy monitoring session to another. A difference curve of the time-intensity curves of the pathology and normal tissue is also produced, which is similarly immune to procedural variations. The motional effects of respiration can be taken into account by detecting the position of a landmark such as the diaphragm in each of the images of the sequence and discarding from processing those which exhibit a change in the position of the landmark relative to the probe.11-25-2010
20100298710THERAPY ASSESSMENT WITH ULTRASOUND CONTRAST AGENTS - An ultrasonic imaging apparatus and method are described for monitoring the progress of therapy for pathology such as lesions, tumors, and metastases by means of contrast agent imaging. A sequence of images are acquired as a bolus of contrast agent infuses the tissue containing the pathology. A contrast wash-in time parameter is calculated for both the tumor and normal tissue, and a ratio is calculated of the two wash-in time parameters (called WITR) which removes the effects of variations in the procedure from one therapy monitoring session to another. A difference curve of the time-intensity curves of the pathology and normal tissue is also produced, which is similarly immune to procedural variations. The motional effects of respiration can be taken into account by detecting the position of a landmark such as the diaphragm in each of the images of the sequence and discarding from processing those which exhibit a change in the position of the landmark relative to the probe.11-25-2010

Michalakis Averkiou, Nicosia CY

Patent application numberDescriptionPublished
20080249409Method of Using a Combination Imaging and Therapy transducer to Dissolve Blood Clots - A combined ultrasound imaging and therapy transducer includes a linear array of imaging transducer elements. First and second linear arrays of therapy transducer elements extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.10-09-2008
20080319316Combination Imaging and Therapy Transducer - A combined ultrasound imaging and therapy transducer includes a linear array of imaging transducer elements. First and second linear arrays of therapy transducer elements extend longitudinally along respective first and second sides of the imaging transducer elements and are canted inwardly toward each other. The imaging and therapy transducer is used with an ultrasound imaging system to locate clots in a region of interest. After the region of interest has been perfused with a microbubble contrast agent, the therapy transducer elements are driven by an amplifier located in the transducer to dissolve the clot. The use of the imaging transducer elements and the therapy transducer elements can be interleaved so that the therapy can be conditioned on an ultrasound image showing substantial destruction of the contrast agent microbubbles, re-perfusion of microbubbles in the region of interest, or the continued presence of the clot.12-25-2008
20100160779ULTRASOUND SYSTEM FOR CEREBRAL BLOOD FLOW IMAGING AND MICROBUBBLE-ENHANCED BLOOD CLOT LYSIS - An ultrasonic diagnostic imaging system is described which utilizes one or more transducer arrays affixed to the head of a patient to diagnose and treat stroke victims. The transducer headset produces a two or three dimensional image of the vasculature inside the cranium, preferably assisted by a microbubble contrast agent. A vascular flow map is produced by the system which may be diagnosed for signs of a blood clot. If a blood clot is detected, a therapeutic beam is transmitted while the contrast agent is present to break up the blood clot by the disruption of microbubbles. The headset may also be used in a monitoring application to detect the recurrence of blood clots in a stroke victim.06-24-2010

Patent applications by Michalakis Averkiou, Nicosia CY

Michalakis Averkiou, Kirkland, WA US

Patent application numberDescriptionPublished
20080234580Ultrasonic Imaging of Perfusion and Blood Flow with Harmonic Contrast Agents - An ultrasonic diagnostic imaging method and system produce diagnostic contrast images depicting both tissue perfusion and flow velocity in larger vessels by utilizing both linear and nonlinear imaging techniques. A sequence of echoes from differently modulated transmit pulses is received and processed in different ways to detect nonlinear signals from microbubble-perfused tissue and Doppler blood flow in larger vessels. The Doppler flow signals may be either linear or nonlinear or a mixture of both. A decision circuit classifies the detected signals for display pixels in a perfusion and/or flow and/or tissue image. Separate perfusion and flow images can be simultaneously displayed or an image of both perfusion and flow can be displayed.09-25-2008
20080249417Non-Linear Ultrasonic Diagnostic Imaging Using Intermodulation Product Signals - An ultrasonic imaging system transmits waveforms containing first and second major frequency components which are intermodulated by passage through a nonlinear medium or interaction with a contrast agent microbubble to produce a difference frequency component. In an illustrated embodiment the second major frequency is twice the frequency of the first major frequency, resulting in a difference frequency signal at the first major frequency. Two differently modulated transmit waveforms are transmitted and the difference frequency component is separated by pulse inversion.10-09-2008
20080275338Nonlinear Ultrasonic Diagnostic Imaging Using Intermodulation Product Signals - An ultrasonic imaging system transmits waveforms containing first and second major frequency components which are intermodulated by passage through a nonlinear medium or interaction with a contrast agent microbubble to produce a difference frequency component. In an illustrated embodiment the transmit waveforms are square waves exhibiting only odd harmonic components. The first and third harmonic components are intermodulated by nonlinear effects to produce a difference frequency signal at the second harmonic frequency.11-06-2008
20080275345Ultrasonic Diagnostic Contrast Imaging at Moderate Mi Levels - A method and device for imaging contrast agents which oscillate nonlinearly in a nondestructive mode at an MI in excess of 0.1 is described. Three transmit pulses are transmitted in each beam direction which are differently modulated. In an illustrated embodiment the transmit pulses are symmetrically differently phase modulated at 0°, 120° and 240°. The echoes received in response to each transmit pulse are stored and combined by a pulse inversion processor. Pulse inversion processing results in separation of the third harmonic to the relative exclusion of the first and second harmonic signal components. Third harmonic images of the contrast image are formed which exhibit a relatively low tissue background.11-06-2008
20090124907Ultrasonic Diagnostic Imaging System and Method for Detecting Lesions of the Liver - Significant liver growths such as HCC lesions are detected during a contrast agent ultrasound exam by their early reception of contrast and brightening following a bolus injection, as compared with surrounding normal tissue and benign growths. A pixel classifier looks for and identifies pixel or voxel regions where this early wash-in of contrast occurs and denotes these pixel or voxel locations in a parametric image. The pixel classifier analyzes pixel or voxel values from a sequence of images and identifies suspicious regions in an image by uniquely coding the points in a parametric liver image where early wash-in occurs.05-14-2009
20090148018Image segmentation technique for displaying myocardial perfusion that does not show the microbubbles in the cardiac chambers - A method and a device for conducting perfusion studies on myocardial tissues with contrast agents is provided. In accordance with the method, ultrasound pulses are transmitted (06-11-2009

Patent applications by Michalakis Averkiou, Kirkland, WA US

Michalakis Averkiou, Bothell, WA US

Patent application numberDescriptionPublished
20080228075Combination Imaging and Therapy Transducer With Therapy Transducer Amplifier - A combined ultrasound imaging and therapy transducer (09-18-2008